|
US20020019527A1
(en)
|
2000-04-27 |
2002-02-14 |
Wei-Bo Wang |
Substituted phenyl farnesyltransferase inhibitors
|
|
WO2001081316A2
(en)
|
2000-04-27 |
2001-11-01 |
Abbott Laboratories |
Substituted phenyl farnesyltransferase inhibitors
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
JP4224566B2
(ja)
|
2000-12-18 |
2009-02-18 |
株式会社医薬分子設計研究所 |
炎症性サイトカイン産生遊離抑制剤
|
|
DE10064823A1
(de)
|
2000-12-22 |
2002-06-27 |
Knoll Ag |
Integrinrezeptorliganden
|
|
US6806265B2
(en)
|
2002-05-16 |
2004-10-19 |
Boehringer Ingelheim International Gmbh |
Non-nucleoside reverse transcriptase inhibitors
|
|
AU2003275225A1
(en)
*
|
2002-09-20 |
2004-04-08 |
Genelabs Technologies, Inc. |
Novel aromatic compounds possessing antifungal or antibacterial activity
|
|
EP1646628A1
(en)
|
2003-07-08 |
2006-04-19 |
Novartis AG |
Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
|
|
US20080220497A1
(en)
|
2003-12-24 |
2008-09-11 |
Flynn Daniel L |
Modulation of protein functionalities
|
|
CN1810777B
(zh)
*
|
2005-01-24 |
2010-09-29 |
上海东浩医药生物企业有限公司 |
一类治疗或预防细菌感染的化合物及其制备方法和用途
|
|
JP2009533315A
(ja)
*
|
2006-04-10 |
2009-09-17 |
ランバクシー ラボラトリーズ リミテッド |
抗菌剤
|
|
US8039502B2
(en)
*
|
2007-07-24 |
2011-10-18 |
The Ohio State University Research Foundation |
Anti-infective agents against intracellular pathogens
|
|
AU2008294535A1
(en)
|
2007-09-04 |
2009-03-12 |
Biolipox Ab |
BIS-aromatic compounds useful in the treatment of inflammation
|
|
WO2009064752A2
(en)
|
2007-11-13 |
2009-05-22 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
US7994166B2
(en)
|
2007-11-13 |
2011-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain
|
|
ES2533826T3
(es)
|
2008-01-18 |
2015-04-15 |
Merck Sharp & Dohme Corp. |
Inhibidores de beta-lactamasa
|
|
US9029411B2
(en)
|
2008-01-25 |
2015-05-12 |
Millennium Pharmaceuticals, Inc. |
Thiophenes and uses thereof
|
|
WO2009118596A2
(en)
|
2008-03-26 |
2009-10-01 |
Glenmark Pharmaceuticals, S. A. |
Phthalimide derivatives as trpa1 modulators
|
|
CN102089278A
(zh)
|
2008-06-11 |
2011-06-08 |
Irm责任有限公司 |
用于治疗疟疾的化合物和组合物
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
DK2385763T3
(en)
|
2009-01-12 |
2018-07-16 |
Aerpio Therapeutics Inc |
METHODS OF TREATING VASCULAR LEAK SYNDROME
|
|
WO2010084402A2
(en)
|
2009-01-22 |
2010-07-29 |
Orchid Research Laboratories Ltd. |
Heterocyclic compounds as phosphodiesterase inhibitors
|
|
ES2726946T3
(es)
|
2009-07-06 |
2019-10-10 |
Aerpio Therapeutics Inc |
Derivados de benzosulfonamida, composiciones de los mismos y su uso en la prevención de la metástasis de las células cancerosas
|
|
US9005579B2
(en)
|
2010-01-05 |
2015-04-14 |
Contrafect Corporation |
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
|
|
WO2011121505A1
(en)
|
2010-03-29 |
2011-10-06 |
Piramal Life Sciences Limited |
Cytokine inhibitors
|
|
KR102143660B1
(ko)
|
2011-06-17 |
2020-08-11 |
화이자 안티-인펙티브스 에이비 |
트랜스-7-옥소-6-(술포옥시)-1,6-디아자비시클로[3,2,1]옥탄-2-카르복스아미드 및 그의 염을 포함하는 헤테로시클릭 화합물의 제조 방법
|
|
EP3052497B1
(en)
|
2011-09-13 |
2017-06-28 |
Wockhardt Limited |
Nitrogen containing compounds and their use
|
|
KR20140129030A
(ko)
*
|
2012-01-18 |
2014-11-06 |
셀슈틱스 코포레이션 |
캔디다증 및 아스퍼질러스 감염을 치료하기 위한 화합물 및 방법
|
|
WO2013123444A1
(en)
|
2012-02-17 |
2013-08-22 |
Amgen Inc. |
Sulfonyl compounds that interact with glucokinase regulatory protein
|
|
US9566310B2
(en)
|
2012-09-10 |
2017-02-14 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno |
Methods of treating muscular dystrophy
|
|
WO2014062938A1
(en)
|
2012-10-19 |
2014-04-24 |
Bristol-Myers Squibb Company |
Rory modulators
|
|
UA111925C2
(uk)
|
2012-12-11 |
2016-06-24 |
Федора Фармасьютікалз Інк. |
БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
|
|
US9707210B2
(en)
|
2013-03-15 |
2017-07-18 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno |
Methods of treating muscular dystrophy
|
|
EP2991648A4
(en)
*
|
2013-05-03 |
2017-01-18 |
Microbiotix, Inc. |
Antimicrobial potentiators
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
CN105473578A
(zh)
|
2013-05-24 |
2016-04-06 |
加州生物医学研究所 |
用于治疗抗药性和持续性结核病的化合物
|
|
GB201310542D0
(en)
|
2013-06-13 |
2013-07-31 |
Antabio Sas |
Compounds
|
|
EP3613740A1
(en)
|
2013-10-08 |
2020-02-26 |
Meiji Seika Pharma Co., Ltd. |
Preparation of a diazabicyclooctane derivative
|
|
US9771364B2
(en)
|
2014-01-21 |
2017-09-26 |
Wockhardt Limited |
Process for preparation of (2S,5R)-6-sulphooxy-7-oxo-2-[((3R)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane
|
|
EP3102578A1
(en)
|
2014-02-03 |
2016-12-14 |
Wockhardt Limited |
A process for preparation of (2s, 5r)-1,6-diaza-bicyclo [3.2.1]octane-2-carbonitrile-7-oxo-6-(sulfooxy)-mono sodium salt
|
|
ES2748029T3
(es)
|
2014-03-13 |
2020-03-12 |
Univ Indiana Res & Tech Corp |
Moduladores alostéricos de proteína núcleo de hepatitis B
|
|
GB2533136A
(en)
*
|
2014-12-11 |
2016-06-15 |
Antabio Sas |
Compounds
|